全外显子组测序分析在神经发育障碍儿童及产前诊断中的应用
回顾性分析70例神经发育障碍(NDDs)儿童及28例产前诊断病例,评估全外显子组测序(WES)联合拷贝数变异(CNV)分析的诊断价值。WES总检出率为30%(21/70),联合CNV分析检出率高于单独SNV/Indel分析(30%,21/70 vs. 20%,14/70)。作者认为WES可能是明确NDDs遗传病因和产前诊断的有效手段。
要点
- 70例NDDs儿童WES检出率为30%(21/70)。
- 联合CNV分析检出率高于单独SNV/Indel分析(30%,21/70 vs. 20%,14/70)。
- 28例产前诊断中6例检出遗传自NDDs父母的变异。
核心结论
- WES可能是明确NDDs患儿遗传病因和产前诊断的有效手段,有利于评估预后以辅助临床治疗和再生育指导。
研究设计与样本
- 回顾性分析2020年6月至2022年3月在湖北省妇幼保健院优生遗传门诊就诊的70例NDDs儿童的临床资料,另有28例为NDDs相关的产前诊断病例。
- 从外周血和羊水中提取基因组DNA,将基于WES的CNV分析纳入常规WES数据分析流程。
主要发现
- 70例NDDs儿童的WES检出率为30%(21/70)。
- 21例阳性病例中,14例(23%)检出SNV/Indel,其中12个变异为未见文献报道的新变异;6例(9.8%)检出CNV;1例(1.6%)检出SNV和CNV的复合杂合变异。
- 综合CNV分析的WES检出率高于单独的SNV/Indel分析(30%,21/70 vs. 20%,14/70)。
- 28例产前诊断病例中,6例检出遗传自NDDs父母的变异,10例未检出与先证者相同的致病变异,其余12例未检出可以解释NDDs表型的明确致病或疑似变异。
- 随访显示5个家庭选择终止妊娠,其他目前暂无异常。
临床怎么用
- 作者认为WES可能是明确NDDs患儿遗传病因和产前诊断的有效手段,有利于评估预后以辅助临床治疗和再生育指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To explore the application value of whole exome sequencing (WES) in the diagnosis of prenatal and postnatal neurodevelopmental disorders (NDDs). A total of 70 patients diagnosed with NDDs who underwent WES at the Medical Genetics Center of the Maternal and Child Health Hospital of Hubei Province between June 2020 and July 2021 were retrospectively analyzed. Genomic DNA was extracted from peripheral blood samples and amniotic fluid. WES-based copy number variant (CNV) analysis was integrated into the routine WES data analysis pipeline. The results showed that a molecular diagnosis rate could be made in 21/70 (30%) cases. Of 21 positive cases, 14 (23%) cases were detected by single-nucleotide variant/small insertion/deletion (SNV/Indel) analysis, of which 12 variants were novel, 6 (9.8%) cases were detected by WES-based CNV analysis, and 1 (1.6%) case was detected by a combination of both. The diagnostic yield of WES combined with CNV analysis was higher than that of SNV/Indel analysis alone (30%, 21/70 vs. 20%, 14/70). Of the 28 prenatally diagnosed cases, 6 cases were found to have inherited parental variation for NDDs, 10 cases were found not to have the same pathogenic variation as the proband, and the remaining 12 cases were found to have no pathogenic or likely pathogenic variation that could explain the NDDs phenotype. Clinical follow-up showed that 5 families opted for abortion and the remaining had no current abnormalities. In conclusion, WES may be an effective method to clarify the genetic etiology and prenatal diagnosis of NDDs, which is helpful in assessing the prognosis to aid clinical management and reproductive guidance. 探讨全外显子组测序(WES)在产前和产后神经发育障碍(NDDs)诊断中的应用价值。本研究回顾性分析2020年6月至2022年3月在湖北省妇幼保健院优生遗传门诊就诊的70例NDDs儿童的临床资料,另有28例为NDDs相关的产前诊断病例,利用WES以明确遗传病因。将基于WES的拷贝数变异(CNV)分析纳入常规WES数据分析。结果显示,70例神经发育障碍儿童的WES检出率为30%(21/70)。在21例阳性病例中,14例检出单核苷酸变异/小插入缺失(SNV/Indel,其中有12个变异是未见文献报道的新变异),6例检出CNV,1例检出SNV和CNV的复合杂合变异。综合CNV分析的WES检出率高于单独的SNV/Indel分析(30%,21/70 vs. 20%,14/70)。28例产前诊断病例中,6例检出遗传自NDDs父母的变异,10例未检出与先证者相同的致病变异,其余12例未检出可以解释NDDs表型的明确致病或疑似变异。随访显示5个家庭选择终止妊娠,其他目前暂无异常。综上,WES可能是明确NDDs患儿遗传病因和产前诊断的有效手段,有利于评估预后以辅助临床治疗和再生育指导。.
引用
- Qin YY, Yao YY, Liu N, et al. [Whole exome sequencing analysis and prenatal diagnosis in children with neurodevelopmental disorders]. Zhonghua Yu Fang Yi Xue Za Zhi. 2023. PMID: 37165823. doi:10.3760/cma.j.cn112150-20220606-00577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。